About
Delphine Larrieu, PhD, is a scientist focused on nuclear envelope dysfunction, premature ageing syndromes, and cell rejuvenation. She is currently a Principal Investigator at the Altos Labs Cambridge Institute of Science, and previously held a Wellcome Trust Sir Henry Dale Fellowship and an Assistant Professorship at the University of Cambridge. Public profiles also describe her as co-founder of Adrestia Therapeutics and a scientific advisor to Shift Bioscience.
Areas of interest
longevityageing biologypremature ageing syndromesprogeriacell rejuvenationnuclear envelope biologyrare diseasetranslational biotechnologysynthetic rescuefunctional genomicsCRISPR screening